Gastroparesis from GLP-1 Medications in Virginia
Last Updated: April 1, 2026
Gastroparesis cases linked to GLP-1 medications are being filed by Virginia residents. Virginia is one of the most challenging states for pharmaceutical plaintiffs due to its strict two-year statute of limitations and its status as one of the few states that does NOT recognize the discovery rule for most tort claims. This means the clock typically starts running when the injury occurs, not when it is discovered, making early legal consultation essential. The Eastern District of Virginia, known as the 'Rocket Docket' for its fast case processing, and the Western District provide the federal litigation venues for the state's 8.6 million residents.
Gastroparesis has been linked to GLP-1 medications including Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity. Virginia residents who developed gastroparesis after using these drugs may qualify for compensation. The product liability statute of limitations in Virginia is 2 years. Cases are pending in federal MDL, and attorneys handle claims on a contingency fee basis — no cost unless you win.
Gastroparesis and GLP-1 Medications
Gastroparesis, commonly referred to as stomach paralysis, occurs when the muscles of the stomach fail to function properly, preventing food from moving through the digestive tract at a normal pace. For Virginia residents who developed gastroparesis after using GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity, the condition can be debilitating and life-altering. Symptoms include severe nausea, persistent vomiting, painful abdominal bloating, dangerous weight loss, and the inability to eat normally. In the most severe cases, patients require hospitalization, feeding tubes, or surgical intervention. The condition can become chronic, requiring ongoing medical management and significantly diminishing quality of life.
The manufacturers of these medications — Novo Nordisk (maker of Ozempic, Wegovy, and Rybelsus) and Eli Lilly (maker of Mounjaro and Trulicity) — are accused of failing to adequately warn patients and prescribing physicians about the risk of gastroparesis. Despite internal data and emerging clinical evidence suggesting a causal link, the drug labels did not include sufficient warnings about the severity and potential permanence of this condition.
For Virginia residents, this means that if you developed gastroparesis while taking a GLP-1 medication, you may have a valid product liability claim. The federal multidistrict litigation (MDL 3094) is consolidating these cases for efficient pretrial proceedings, while preserving each plaintiff's individual right to trial.
Recognizing Gastroparesis from GLP-1 Drugs
If you are a Virginia resident who used Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity and experienced any of the following symptoms, you may have developed gastroparesis as a result:
Severe nausea and vomiting
Abdominal pain and bloating
Feeling full after small amounts of food
Unintentional weight loss
Acid reflux
Diagnosis
Gastroparesis is typically confirmed through gastric emptying study (ges). If you are experiencing symptoms but have not yet received a formal diagnosis, an attorney can help coordinate appropriate medical evaluation as part of your case. Having documented medical evidence strengthens your claim significantly.
Filing a Gastroparesis Claim in Virginia
Virginia residents who developed gastroparesis after using GLP-1 medications have specific legal options and deadlines. The statute of limitations for product liability claims in Virginia is 2 years, and the personal injury statute of limitations is 2 years.
Virginia has limited application of the discovery rule in product liability cases. This means that filing deadlines may be calculated more strictly than in other states, and delays in seeking legal counsel could jeopardize your ability to file a claim. It is especially important for Virginia residents to act promptly.
Cases may be filed in the Virginia Circuit Courts at the state level or in federal court through the Eastern District of Virginia (or other Virginia federal districts). Most GLP-1 injury cases are being coordinated through the federal MDL for pretrial proceedings.
Virginia legal landscape: Virginia is one of the few states that still applies contributory negligence as a complete bar to recovery. The state does not recognize strict liability for product defect claims — plaintiffs must proceed under negligence or breach of warranty theories. These rules make Virginia one of the most defense-friendly jurisdictions for pharmaceutical litigation. Residents in Virginia Beach, Norfolk, Richmond, Arlington, and Chesapeake and surrounding areas should consult with an attorney to evaluate their potential gastroparesis claim.
Personal Injury SOL
2 years
Product Liability SOL
2 years
Discovery Rule
Limited
GLP-1 Drugs Linked to Gastroparesis
The following GLP-1 receptor agonist medications have been linked to gastroparesis in ongoing litigation. If you used any of these drugs in Virginia and developed gastroparesis, you may qualify for a claim:
Ozempic
Semaglutide injection by Novo Nordisk. Prescribed for type 2 diabetes.
Wegovy
Semaglutide injection by Novo Nordisk. Prescribed for weight management.
Mounjaro
Tirzepatide injection by Eli Lilly. Prescribed for type 2 diabetes and weight management.
Rybelsus
Oral semaglutide by Novo Nordisk. Prescribed for type 2 diabetes.
Saxenda
Liraglutide injection by Novo Nordisk. Prescribed for weight management.
Trulicity
Dulaglutide injection by Eli Lilly. Prescribed for type 2 diabetes.
Do You Qualify for a Gastroparesis Claim in Virginia?
Virginia residents may be eligible to file a gastroparesis claim if the following criteria apply:
Used a GLP-1 Medication
You were prescribed and used Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity or another GLP-1 receptor agonist medication.
Diagnosed with Gastroparesis
You received a medical diagnosis of gastroparesis through gastric emptying study (ges).
Injury Occurred After Drug Use
Your gastroparesis developed after you began taking the GLP-1 medication, establishing a timeline consistent with causation.
Within Virginia's Filing Deadline
Your claim falls within Virginia's product liability statute of limitations (2 years). An attorney can evaluate your specific timeline.
Gastroparesis in Virginia: FAQ
What is gastroparesis and how is it linked to GLP-1 medications in Virginia?
Stomach paralysis causing severe nausea, vomiting, and inability to digest food normally. GLP-1 medications including Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity have been linked to an increased risk of developing this condition. Virginia residents who were prescribed these medications and subsequently developed gastroparesis may be eligible to file a lawsuit seeking compensation for their injuries, medical expenses, and other damages.
What are the symptoms of gastroparesis caused by Ozempic or other GLP-1 drugs?
Common symptoms of gastroparesis include severe nausea and vomiting, abdominal pain and bloating, feeling full after small amounts of food, unintentional weight loss, acid reflux. If you experienced these symptoms after taking Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity in Virginia, you should seek medical attention immediately and consider having your case evaluated for potential legal action.
How is gastroparesis diagnosed for purposes of a GLP-1 lawsuit?
Gastroparesis is typically diagnosed through gastric emptying study (ges). For Virginia residents filing a GLP-1 injury claim, medical documentation confirming your diagnosis is important for establishing your case. If you have not yet been formally diagnosed but are experiencing symptoms, your attorney can help coordinate appropriate medical evaluation.
What is the statute of limitations for a gastroparesis claim in Virginia?
In Virginia, the statute of limitations for product liability claims is 2 years. Virginia has limited discovery rule application, so prompt action is especially important. Consult with an attorney to determine your exact deadline.
What compensation can I receive for gastroparesis caused by GLP-1 drugs in Virginia?
Virginia residents who qualify may recover compensation for medical expenses (including hospitalization, feeding tubes, and ongoing treatment), lost wages, pain and suffering, emotional distress, and diminished quality of life. The amount depends on the severity of your gastroparesis and its impact on your daily life.
Is there any cost to file a gastroparesis claim in Virginia?
There is no upfront cost. Attorneys handling GLP-1 gastroparesis cases in Virginia work on a contingency fee basis, meaning they only receive payment if you receive compensation through settlement or trial verdict. NuLegal's initial case review is completely free with no obligation.
Related Resources
Other GLP-1 Injuries in Virginia
Virginia Residents: Get Your Free Case Review
If you developed gastroparesis after using Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity, time may be limited. Virginia's product liability statute of limitations is 2 years. Get a free, no-obligation evaluation today.
Free Case ReviewAdvertisement
Disclosure: NuLegal operates as a legal referral service. Attorney Ashkaan Hassan evaluates claims and refers qualified cases to specialized trial firms, earning a referral fee from the attorney's share of any recovery. Clients never pay out of pocket.